Intravenous iron isomaltoside treatment of women suffering from severe fatigue after postpartum hemorrhage

References

• WHO Global Database on Anaemia. Worldwide prevalence of anaemia 1993–2005. Atlanta: Center for Disease Control and Prevention; 2008.
   Google Scholar
• World Health Organization. WHO recommendations for the prevention and treatment of postpartum haemorrhage; 2012.
   Google Scholar
• Sundhedsstyrelsen [Internet]. National klinisk retningslinje om Indikation for transfusion Med blodkomponenter; [cited 2017 Dec 21]. Available from: https://sundhedsstyrelsen.dk/da/udgivelser/2014/∼/media/EEA1EA90C15E4A97B9E786D2850B3664.ashx
   Google Scholar
• Goldberg ND. Iron deficiency anemia in patients with inflammatory bowel disease. Clin Exp Gastroenterol. 2013;6:61–70.
   PubMedGoogle Scholar
• KDIGO clinical practice guideline for anemia in chronic kidney disease [Internet]; 2012. Vol. 2; [cited 2017 Dec 21]. Available from: http://www.kdigo.org/clinical_practice_guidelines/pdf/KDIGO-Anemia%20GL.pdf
   Google Scholar
• Dignass AU, Gasche C, Bettenworth D, et al. European consensus on the diagnosis and management of iron deficiency and anaemia in inflammatory bowel diseases. J Crohns Colitis. 2015;9:211–222.
   PubMed Web of Science ®Google Scholar
• Gasche C, Berstad A, Befrits R, et al. Guidelines on the diagnosis and management of iron deficiency and anemia in inflammatory bowel diseases. Inflamm Bowel Dis. 2007;13:1545–1553.
   PubMed Web of Science ®Google Scholar
• Hildebrandt PR, Bruun NE, Nielsen OW, et al. Effects of administration of iron isomaltoside 1000 in patients with chronic heart failure. A pilot study. TATM. 2010;11:131–137.
   Google Scholar
• Wikström B, Bhandari S, Barany P, et al. Iron isomaltoside 1000: a new intravenous iron for treating iron deficiency in chronic kidney disease. J Nephrol. 2011;24:589–596.
   PubMed Web of Science ®Google Scholar
• Reinisch W, Staun M, Tandon RK, et al. A randomized, open-label, non-inferiority study of intravenous iron isomaltoside 1,000 (Monofer) compared with oral iron for treatment of anemia in IBD (PROCEED). Am J Gastroenterol. 2013;108:1877–1888.
   PubMed Web of Science ®Google Scholar
• Reinisch W, Altorjay I, Zsigmond F, et al. A 1-year trial of repeated high-dose intravenous iron isomaltoside 1000 to maintain stable hemoglobin levels in inflammatory bowel disease. Scand J Gastroenterol. 2015;50:1226–1233.
   PubMed Web of Science ®Google Scholar
• Bhandari S, Kalra PA, Kothari J, et al. A randomized, open-label trial of iron isomaltoside 1000 (Monofer®) compared with iron sucrose (Venofer®) as maintenance therapy in haemodialysis patients. Nephrol Dial Transplant. 2015;30:1577–1589.
   PubMed Web of Science ®Google Scholar
• Kalra PA, Bhandari S, Saxena S, et al. A randomized trial of iron isomaltoside 1000 versus oral iron in non-dialysis-dependent chronic kidney disease patients with anaemia. Nephrol Dial Transplant. 2016;31:646–655.
   PubMed Web of Science ®Google Scholar
• Birgegård G, Henry D, Glaspy J, et al. A randomized, noninferiority trial of intravenous iron isomaltoside versus oral iron sulfate in patients with nonmyeloid malignancies and anemia receiving chemotherapy: The PROFOUND Trial. Pharmacotherapy. 2016;36:402–414.
   PubMed Web of Science ®Google Scholar
• Dahlerup JF, Jacobsen BA, van der Woude J, et al. High-dose fast infusion of parenteral iron isomaltoside is efficacious in inflammatory bowel disease patients with iron-deficiency anaemia without profound changes in phosphate or fibroblast growth factor 23. Scand J Gastroenterol. 2016;51:1332–1338.
   PubMed Web of Science ®Google Scholar
• Derman R, Roman E, Modiano MR, et al. A randomized trial of iron isomaltoside versus iron sucrose in patients with iron deficiency anemia. Am J Hematol. 2017;92:286–291.
   PubMed Web of Science ®Google Scholar
• Johansson PI, Rasmussen AS, Thomsen LL. Intravenous iron isomaltoside 1000 (Monofer®) reduces postoperative anaemia in preoperatively non-anaemic patients undergoing elective or subacute coronary artery bypass graft, valve replacement or a combination thereof: a randomized double-blind placebo-controlled clinical trial (the PROTECT trial). Vox Sang. 2015;109:257–266.
   PubMed Web of Science ®Google Scholar
• Holm C, Thomsen LL, Norgaard A, et al. Single-dose intravenous iron infusion or oral iron for treatment of fatigue after postpartum haemorrhage: a randomized controlled trial. Vox Sang. 2017;112:219–228.
   PubMed Web of Science ®Google Scholar
• Holm C, Thomsen LL, Norgaard A, et al. Single-dose intravenous iron infusion versus red blood cell transfusion for the treatment of severe postpartum anaemia: a randomized controlled pilot study. Vox Sang. 2017;112:122–131.
   PubMed Web of Science ®Google Scholar
• Holm C, Thomsen LL, Norgaard A, et al. Intravenous iron isomaltoside 1000 administered by high single-dose infusions or standard medical care for the treatment of fatigue in women after postpartum haemorrhage: study protocol for a randomised controlled trial. Trials. 2015;16:5.
   PubMed Web of Science ®Google Scholar
• Jansen AJ, Essink-Bot ML, Duvekot JJ, et al. Psychometric evaluation of health-related quality of life measures in women after different types of delivery. J Psychosom Res. 2007;63:275–281.
   PubMed Web of Science ®Google Scholar
• Gibson J, McKenzie-McHarg K, Shakespeare J, et al. A systematic review of studies validating the Edinburgh Postnatal Depression Scale in antepartum and postpartum women. Acta Psychiatr Scand. 2009;119:350–364.
   PubMed Web of Science ®Google Scholar
• Sheikh M, Hantoushzadeh S, Shariat M, et al. The efficacy of early iron supplementation on postpartum depression, a randomized double-blind placebo-controlled trial. Eur J Nutr. 2017;56:901–908.
   PubMed Web of Science ®Google Scholar
• Holm C, Thomsen LL, Norgaard A, et al. Iron concentration in breast milk normalised within one week of a single high-dose infusion of iron isomaltoside in randomised controlled trial. Acta Paediatr. 2017;106:256–260.
   PubMed Web of Science ®Google Scholar
• Kavle JA, Stoltzfus RJ, Witter F, et al. Association between anaemia during pregnancy and blood loss at and after delivery among women with vaginal births in Pemba Island, Zanzibar, Tanzania. J Health Popul Nutr. 2008;26:232–240.
   PubMed Web of Science ®Google Scholar
• Jaleel R, Khan A. Post-partum haemorrhage – a risk factor analysis. Mymensingh Med J. 2010;19:282–289.
   PubMedGoogle Scholar
• Frass KA. Postpartum hemorrhage is related to the hemoglobin levels at labor: observational study. Alex J Med. 2015;51:333–337.
   Web of Science ®Google Scholar